Joachim Yahalom
#181,042
Most Influential Person Across History
American-Israeli radiation oncologist
Joachim Yahalom's AcademicInfluence.com Rankings
Download Badge
Medical Philosophy
Joachim Yahalom's Degrees
- Doctorate Medicine Harvard University
- PhD Radiation Oncology Stanford University
Why Is Joachim Yahalom Influential?
(Suggest an Edit or Addition)Joachim Yahalom's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes (2008) (2360)
- A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. (2001) (1010)
- Treatment for primary CNS lymphoma: the next step. (2000) (558)
- Long-term survival in primary CNS lymphoma. (1998) (542)
- Combined modality therapy for primary CNS lymphoma. (1992) (518)
- Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). (2014) (450)
- Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. (2006) (449)
- A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. (2001) (399)
- How I treat extramedullary acute myeloid leukemia. (2011) (394)
- Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. (2004) (372)
- Superior Vena Cava Syndrome with Malignant Causes (2007) (367)
- NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. (2010) (355)
- Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. (2007) (340)
- Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. (2013) (337)
- Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. (1998) (292)
- Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. (2004) (291)
- Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. (1999) (290)
- Intensity-modulated tangential beam irradiation of the intact breast. (1999) (284)
- Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. (2015) (272)
- Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. (2006) (261)
- NCCN clinical practice guidelines in oncology: multiple myeloma. (2009) (260)
- Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. (2012) (251)
- Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. (2003) (249)
- Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (243)
- Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. (1991) (242)
- Delayed neurotoxicity in primary central nervous system lymphoma. (2005) (233)
- Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. (2014) (230)
- Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma. (2010) (224)
- Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. (2005) (217)
- Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. (1991) (213)
- T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. (1998) (212)
- Primary CNS lymphoma (1990) (212)
- Primary bone lymphoma: Treatment results and prognostic factors with long‐term follow‐up of 82 patients (2006) (208)
- Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. (1985) (207)
- Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. (1992) (206)
- PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. (2015) (206)
- Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. (2006) (184)
- Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002. (2003) (179)
- Clinical practice. Superior vena cava syndrome with malignant causes. (2007) (178)
- Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma (2007) (170)
- Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. (1990) (162)
- Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy‐proven primary refractory Hodgkin's disease (2004) (153)
- The involved field is back: issues in delineating the radiation field in Hodgkin's disease. (2002) (151)
- Second malignant neoplasms and cardiovascular disease following radiotherapy. (2012) (139)
- FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. (2005) (138)
- Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma (2009) (134)
- Non‐hodgkin's lymphomas (2010) (133)
- NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018. (2018) (132)
- Non-Hodgkin's lymphomas, version 4.2014. (2014) (131)
- NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. (2016) (127)
- Radiotherapy in the management of plasma cell tumors. (2000) (125)
- High-dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis. (2000) (124)
- Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. (2017) (122)
- Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease. (1996) (122)
- Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. (1991) (121)
- Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). (2018) (121)
- Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. (1993) (121)
- Autologous transplantation for relapsed or primary refractory peripheral T‐cell lymphoma (2006) (121)
- Primary mediastinal large B‐cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at memorial Sloan Kettering from 1980 to 1999 (2005) (121)
- [Treatment of metastatic breast cancer]. (1986) (117)
- 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. (1994) (115)
- Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape. (2018) (115)
- Effect of epidermal growth factor on the growth and radiation sensitivity of human breast cancer cells in vitro. (1994) (115)
- Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma (2003) (112)
- NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. (2007) (110)
- Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma. (2003) (110)
- Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. (1992) (109)
- Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy (2009) (105)
- Combined‐modality therapy in the treatment of primary central nervous system lymphoma in AIDS (1994) (104)
- Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. (1992) (103)
- Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. (2008) (103)
- Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (102)
- Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. (2017) (101)
- Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. (2012) (100)
- Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy (2014) (96)
- Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma. Results of a prospective randomized study (1993) (94)
- Intensity-modulated radiotherapy for lymphoma involving the mediastinum. (2005) (92)
- Radiation therapy for chloroma (granulocytic sarcoma). (2011) (89)
- Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. (2011) (86)
- High‐dose chemo‐radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre‐transplant functional imaging (2010) (84)
- Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations. (1991) (81)
- Low-grade MALT lymphoma of the stomach: a review of treatment options. (2000) (81)
- Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. (2019) (77)
- Diffuse Large B-Cell Lymphoma Version 1.2016. (2016) (76)
- The influence of older age on breast cancer treatment decisions and outcome. (1996) (75)
- Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells. (1998) (75)
- Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. (2018) (73)
- Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events. (1997) (72)
- Non-Hodgkin's lymphomas, version 1.2013. (2013) (71)
- The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma (1999) (71)
- Adverse prognostic significance of CD20 positive Reed–Sternberg cells in classical Hodgkin's disease * (2004) (70)
- ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic (2020) (70)
- Degradation of sulfated proteoglycans in the subendothelial extracellular matrix by human platelet heparitinase. (1984) (70)
- Chemoradiotherapy for primary CNS lymphoma (2005) (69)
- Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. (2020) (68)
- Multiple myeloma, version 1.2013. (2013) (68)
- Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines (2018) (67)
- Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. (2016) (67)
- Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high‐dose methotrexate‐based chemotherapy (2008) (63)
- Transformation in the use of radiation therapy of Hodgkin lymphoma: New concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT) (2005) (63)
- NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016. (2016) (61)
- Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma. (2008) (59)
- Multiple myeloma. Clinical practice guidelines in oncology. (2007) (59)
- Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long‐term survivors of Hodgkin's disease: July 9–16, 2003, Bellagio, Italy (2005) (58)
- Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group. (2018) (57)
- Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology. (2015) (56)
- Radiation treatment planning techniques for lymphoma of the stomach. (2005) (55)
- The relationship between twenty missense ATM variants and breast cancer risk: the Multiethnic Cohort. (2003) (55)
- NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. (2018) (54)
- Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. (2015) (54)
- Basic fibroblast growth factor confers growth inhibition and mitogen-activated protein kinase activation in human breast cancer cells. (1997) (52)
- Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. (1977) (51)
- R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy (2005) (49)
- Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma (2017) (49)
- Clinical spectrum of pericardial effusion as the presenting feature of hypothyroidism. (1983) (48)
- The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma (2009) (47)
- NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines (2017) (47)
- Radiation therapy after breast augmentation or reconstruction in early or recurrent breast cancer (1990) (47)
- Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making (2020) (47)
- Non-Hodgkin's lymphomas, version 2.2014. (2014) (46)
- Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015. (2015) (46)
- Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology. (2006) (46)
- Sarcoidosis following chemotherapy for Hodgkin's disease. (1994) (45)
- Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2021) (45)
- Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies. (2020) (44)
- Hodgkin lymphoma, version 2.2015. (2015) (44)
- T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. (2013) (44)
- Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines. (2020) (44)
- Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity. (2008) (43)
- Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. (2012) (43)
- Encouraging experience in the treatment of nasal type extra-nodal NK/T-cell lymphoma in a non-Asian population (2016) (42)
- Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers. (2002) (42)
- Alternatives in the Management of Gastric Lymphoma. (1991) (42)
- Whole-brain radiotherapy in primary CNS lymphoma. (2011) (40)
- Overexpression of basic fibroblast growth factor (FGF–2) downregulates Bcl–2 and promotes apoptosis in MCF–7 human breast cancer cells (1999) (40)
- Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT). (2005) (39)
- The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (37)
- Disparities in survival by insurance status in patients with Hodgkin lymphoma (2015) (37)
- Radiation‐Induced Salivary Gland Tumors: A Report of 18 Cases and a Review of the Literature (2003) (37)
- Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes (2016) (37)
- Limited resection for breast cancer: a study of inked specimen margins before radiotherapy. (1987) (37)
- Challenges and opportunities in primary CNS lymphoma: A systematic review. (2017) (37)
- [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies. (2011) (36)
- The patients perception of her breast following radiation and limited surgery. (1989) (35)
- Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation (2019) (35)
- MALT Lymphomas: A radiation oncology viewpoint (2001) (34)
- Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. (2010) (34)
- Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. (1989) (34)
- Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow. (1992) (34)
- Non‐Hodgkin's lymphoma associated with pregnancy a report of six cases, with a review of the literature (1985) (33)
- Hodgkin disease/lymphoma. Clinical practice guidelines in oncology. (2006) (33)
- Clinical Features and Outcome of Primary Pancreatic Lymphoma (2015) (32)
- Primary CNS lymphoma: managing patients with spontaneous and AIDS-related disease. (1987) (32)
- Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. (1987) (31)
- Early experience using salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy (2020) (31)
- Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival. (2015) (30)
- Acute myocardial infarction with normal coronary arteriogram after mantle field radiation therapy for Hodgkin's disease (1983) (30)
- Idiopathic cholestasis as a paraneoplastic phenomenon in Hodgkin's lymphoma. (2006) (30)
- Breast cancer after Hodgkin disease: hope for a safer cure. (2003) (29)
- Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. (2008) (29)
- Advances in biology, diagnostics, and treatment of Hodgkin's disease. (2006) (29)
- Four cycles of chemotherapy and regional radiation therapy for clinical early‐stage and intermediate‐stage Hodgkin's disease (1992) (29)
- Radiation in Central Nervous System Leukemia: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (29)
- Non-Hodgkin's Lymphomas, version 3.2012: Featured updates to the NCCN guidelines (2012) (29)
- Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies (2018) (29)
- Primary intraocular lymphoma: treatment outcomes with ocular radiation therapy alone (2014) (28)
- The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. (1996) (27)
- Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. (2020) (27)
- Pathways that Regulate Autophagy and their Role in Mediating Tumor Response to Treatment (2006) (27)
- Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma. (2006) (27)
- Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era. (2016) (26)
- Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG) (2017) (26)
- Recurrent Neurotropic Chloroma: Report of a Case and Review of the Literature (2010) (26)
- Long-term cardiac and pulmonary complications of cancer therapy. (2008) (26)
- Long-term cardiac and pulmonary complications of cancer therapy. (2011) (25)
- NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017. (2017) (25)
- Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation (2015) (25)
- Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis. (2015) (25)
- The role of radiation therapy in the management of primary central nervous system lymphoma (2015) (25)
- Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group. (2018) (24)
- Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group. (2021) (24)
- Very low utility of surveillance imaging in early‐stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy (2015) (23)
- The concept and evolution of involved site radiation therapy for lymphoma (2015) (23)
- The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). (2019) (23)
- FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma. (2013) (23)
- Autologous bone marrow transplantation for refractory or relapsed Hodgkin's disease: the Memorial Sloan-Kettering Cancer Center experience using high-dose chemotherapy with or without hyperfractionated accelerated total lymphoid irradiation. (1991) (22)
- Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma. (2018) (22)
- Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations (2016) (21)
- Radiotherapy of Follicular Lymphoma: Updated Role and New Rules (2014) (21)
- Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. (1995) (21)
- Radiation-induced micronuclei formation in human breast cancer cells: dependence on serum and cell cycle distribution. (1997) (21)
- Role of Radiation Therapy in Hodgkin’s Lymphoma (2009) (20)
- Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: a systematic review. (2009) (20)
- Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant. (2018) (20)
- Autologous bone marrow transplantation. (1991) (19)
- The case for adjuvant radiation therapy in advanced Hodgkin's disease. (1996) (18)
- Non-Hodgkin's Lymphomas, version 3.2012. (2012) (18)
- Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma (2021) (18)
- Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era. (2020) (18)
- MSKCC EARLY EXPERIENCE USING RADIOTHERAPY AS A BRIDGING STRATEGY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA BEFORE CD19 CAR T THERAPY (2019) (18)
- Platelet-tumor cell interaction with the subendothelial extracellular matrix: relationship to cancer metastasis. (1985) (17)
- Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma. (2016) (17)
- Radiation therapy in the treatment of lymphoma. (1999) (17)
- Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor (2001) (17)
- Changing role and decreasing size: Current trends in radiotherapy for hodgkin’s disease (2002) (17)
- Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience. (2017) (17)
- Overexpression of basic fibroblast growth factor in MCF‐7 human breast cancer cells: Lack of correlation between inhibition of cell growth and MAP kinase activation (1998) (16)
- A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies. (2014) (16)
- Hodgkin disease/lymphoma. (2008) (16)
- Radiation therapy for leukemia cutis. (2011) (15)
- Lactation following conservation surgery and radiotherapy for breast cancer (1991) (15)
- Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG. (2019) (15)
- Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells (1999) (15)
- Hodgkin lymphoma. (2021) (14)
- The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. (2004) (14)
- NCCN preliminary non-Hodgkin's lymphoma practice guidelines. (1997) (14)
- Radiation therapy after R-CHOP for diffuse large B-cell lymphoma: the gain remains. (2010) (14)
- Diffuse large cell lymphoma. Prognostic factors with treatment. (1991) (14)
- Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients. (2021) (13)
- Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). (2018) (13)
- Diagnostic and Therapeutic Considerations for Extramedullary Leukemia (2020) (13)
- NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022. (2022) (12)
- Outcome After Radiation Therapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement. (2017) (12)
- Sarcoid in cancer patients: clinical characteristics and associated disease status. (2015) (12)
- Indolent non-Hodgkin lymphoma primarily involving the hard palate: outcome following radiotherapy (2013) (12)
- Eukaryotic Initiation Factor 2α - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment (2013) (12)
- Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population (2020) (11)
- Favorable early-stage Hodgkin lymphoma. (2006) (11)
- Secondary leukemia following treatment of Hodgkin's disease: ultrastructural and cytogenetic data in two cases with a review of the literature. (1983) (11)
- Cutaneous Rosai-Dorfman disease of the right ear responsive to radiotherapy. (2012) (10)
- The use of lymphoscintigraphy in treatment planning of primary breast cancer. (1989) (10)
- Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix. (1988) (10)
- A novel reduced intensity conditioning regimen for patients with high-risk hematological malignancies undergoing allogeneic stem cell transplantation (2016) (10)
- Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. (2005) (10)
- TARC Predicts PET-Normalization and Event Free Survival in Relapsed/Refractory Hodgkin Lymphoma Patients Treated With Brentuximab Vedotin. (2015) (10)
- Duct carcinoma-in-situ of the breast: Does conservation surgery and radiotherapy provide acceptable local control? (1990) (10)
- Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma (2014) (10)
- OUTCOME OF CURATIVE RADIOTHERAPY FOR LOCALISED FOLLICULAR LYMPHOMA IN THE ERA OF 18F‐FDG PET‐CT STAGING: AN INTERNATIONAL COLLABORATIVE STUDY ON BEHALF OF ILROG (2017) (10)
- Extranodal MALT Lymphoma of the Right Triceps Muscle following Influenza Vaccine Injection: A Rare Case with an Interesting Presentation (2011) (10)
- Factors affecting the outcome of autologous bone marrow transplantation. (1991) (9)
- Evidence-based breast cancer screening guidelines for women who received chest irradiation at a young age. (2013) (9)
- PET-Computed Tomography for Radiation Treatment Planning of Lymphoma and Hematologic Malignancies. (2011) (9)
- Primary follicular lymphoma of the gastrointestinal tract: effect of stage, symptoms and treatment choice on outcome (2013) (9)
- Treatment Options for Hodgkin's Disease During Pregnancy. (1990) (9)
- Older patients with early-stage diffuse large B-cell lymphoma: the role of consolidation radiotherapy after chemoimmunotherapy (2017) (9)
- Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival (2016) (9)
- High Complete Response Rate Observed with Second-Line Chemo-Immunotherapy with Pembrolizumab and GVD (Gemcitabine, Vinorelbine, and Liposomal Doxorubicin) in Relapsed and Refractory Classical Hodgkin Lymphoma (2019) (9)
- Modified SMILE (mSMILE) is Active in the Treatment of Extranodal Natural Killer/T-Cell Lymphoma: A Single Center US Experience (2014) (9)
- Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage—Case Report (2017) (8)
- Omitting radiotherapy after attaining FDG PET-negative status following chemotherapy alone for Hodgkin lymphoma: A randomized study caveat (2007) (8)
- Primary cns lymphoma: Long-term results of an intensive combined modality therapy (1994) (8)
- 43. H. Pylori-Independent Malt Lymphoma of the Stomach: 10-Year Experience with 51 Patients Treated with Radiation Alone (2003) (8)
- Chemotherapy only in early-stage Hodgkin lymphoma: More relapses but “same” (or possibly worse) survival – Reconsidering the misguided trend to omit radiotherapy (2014) (8)
- Imaging of late complications from mantle field radiation in lymphoma patients. (2008) (8)
- Effective treatment of malt lymphoma of the stomach with radiation alone (1998) (7)
- Relapsed and Refractory Primary Mediastinal Diffuse Large B-Cell Lymphoma: Outcome with ICE-Based Treatment. (2006) (7)
- Radiation therapy for stage III follicular lymphoma-often ignored, but still effective. (2001) (7)
- Does radiotherapy still have a place in Hodgkin lymphoma? (2009) (7)
- Novel Agents May be Preferable to Chemotherapy for Large B-Cell Lymphoma Progressing after CD19-CAR-T: A Multicenter Observational Study (2021) (7)
- BASELINE METABOLIC TUMOR VOLUME IS AN INDEPENDENT PROGNOSTIC FACTOR FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA PATIENTS RECEIVING PET‐ADAPTED SALVAGE THERAPY WITH BRENTUXIMAB VEDOTIN AND AUGMENTED ICE (2017) (7)
- Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease. (2018) (7)
- Immunosuppression prior to marrow transplantation for sensitized aplastic anemia patients: comparison of TLI with TBI. (1988) (7)
- Patients with H pylori-independent MALT lymphoma are curable with radiotherapy. (2011) (7)
- SU‐FF‐J‐83: Inaccuracy of Fixed Threshold Segmentation for PET (2006) (7)
- Early-Stage Follicular Lymphoma: What Is the Preferred Treatment Strategy? (2018) (7)
- Radiotherapy for lung cancer: can IMRT decrease the risk of esophagitis (2001) (6)
- Results of autologous bone marrow transplantation for acute leukaemia. (1989) (6)
- Retinopathy in survivors of primary central nervous system lymphoma (2006) (6)
- Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? (2021) (6)
- The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again (2011) (6)
- Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease. (2020) (6)
- Radiotherapy for Hodgkin lymphoma (2011) (5)
- Early-Stage Hodgkin Disease: The Utilization of Radiation Therapy and Its Impact on Overall Survival (2014) (5)
- Modified SMILE in the Treatment of Natural Killer T-Cell Lymphoma, Nasal and Nasal Type: A Single Center US Experience (2011) (5)
- Rosai-Dorfman Disease-Utility of 18F-FDG PET/CT for Initial Evaluation and Follow-up. (2020) (5)
- Primary Mediastinal Large B Cell Lymphoma: Elucidating Optimal Therapy and Prognostic Factors; an Analysis in 141 Consecutive Patients Treated at Memorial Sloan Kettering from 1980–1999. (2004) (5)
- Cancer Survivorship. Preface. (2008) (5)
- 150 : Reduced-Dose Whole Brain Radiotherapy (WBRT) Following Complete Response to Immuno-Chemotherapy in Patients With Primary CNS Lymphoma (PCNSL) (2006) (5)
- Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma (2016) (5)
- Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy (2018) (5)
- Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2020) (5)
- A Prospective Study of 18FDG-PET with CT scan Co-registration for Radiation Treatment Planning of Lymphoma and Hematologic Malignancies (2010) (5)
- A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED‐SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA (2017) (5)
- Abstract of ASTRO proffered papers, posters, and scientific exhibit to be presentedLong-term sequelae of total body irradiation, high dose chemotherapy, and autologous bone marrow transplantation for non-Hodgiqn's lymphoma (1994) (4)
- Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma. (2020) (4)
- Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition. (2013) (4)
- Recommendations for the clinical management of the elderly patient with malignant lymphoma. (2018) (4)
- NCCN practice guidelines for multiple myeloma (1998) (4)
- Cancer survivorship: facing forward. (2008) (4)
- Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma. (2010) (4)
- The effect of ABVD chemotherapy with and without mediastinal irradiation on pulmonary function and symptomsin early-stage Hodgkin's disease (1994) (4)
- Normalization of FDG-PET Pre-ASCT with Additional Non-Cross Resistant Chemotherapy Improves EFS in Patients with Relapsed and Primary Refractory Hodgkin Lymphoma-Memorial Sloan Kettering Protocol 04-047 (2008) (4)
- Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG) (2013) (3)
- Re-visiting the role of radiation therapy in Hodgkin's disease. (1995) (3)
- Cost-effectiveness analysis of first-line treatments for early-stage, low-grade follicular lymphoma. (2017) (3)
- JNCCN NCCN Task Force Report : PET / CT Scanning in Cancer (2007) (3)
- Chapter 18 – Total Body Irradiation (2012) (3)
- A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma (2017) (3)
- Favorable Outcome in Stage I-II Mantle Cell Lymphoma: A Report of 160 Patients From the International Lymphoma Radiation Oncology Group (ILROG) (2014) (3)
- Patients with Relapsed/Refractory Large Cell Lymphoma Who Were Also Refractory to Salvage Chemotherapy: Outcome with Salvage Radiation Therapy Followed by Autologous Stem Cell Transplant (2018) (3)
- by Human Platelet Heparitinase (1984) (3)
- Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy (2019) (3)
- Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL). (2020) (3)
- The presence of a bulky mediastinal mass of 7 cm or greater in diameter confers an adverse prognosis to patients with advanced Hodgkin lymphoma in case of negative interim PET/CT (2021) (3)
- Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma (2019) (3)
- Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients with primary CNS lymphoma (PCNSL). (2004) (3)
- SP-0496: Indications to radiotherapy for lymphoma in 2016: what is standard of care and what remains controversial? (2016) (3)
- Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection. (1985) (3)
- Modern radiation therapy for nodal non-Hodgkin lymphom-target definition and dose guidelines from the international lymphoma radiation oncology group (2017) (3)
- Making Every Single Gray Count: Involved Site Radiation Therapy Delineation Guidelines for Hematological Malignancies. (2020) (2)
- Hodgkin Lymphoma Version 1 . 2017 Clinical Practice Guidelines in Oncology (2017) (2)
- Non-Hodgkin’s Lymphomas, Version 4.2014: Clinical Practice Guidelines in Oncology (2014) (2)
- Principles of Radiation Techniques in Hodgkin Lymphoma (2011) (2)
- Clinical Outcomes and Patterns of Relapse in 300 Patients With Early and Advanced-Stage Marginal Zone Lymphoma (2013) (2)
- Pre-Transplant Evaluation with Both CT and PET Following Second-Line Therapy Is Essential for Predicting Outcome in Patients with Transplant- Eligible Relapsed and Primary Refractory Hodgkin Lymphoma (2008) (2)
- Salvage Therapy for Relapsed and Refractory Hodgkin Lymphoma (2011) (2)
- Hodgkin's disease—Part I: Epidemiology, pathology, staging and management of early stage disease (1996) (2)
- Grade 3A follicular lymphoma can be effectively controlled with very low-dose radiation therapy (2020) (2)
- Optimal matchline blocking and matchline dosimetry for lymphoma patients. (2000) (2)
- Local control and the sequencing of adjuvant systemic therapy with primary radiation for patients with early breast cancer (1992) (2)
- HIGHLY FAVORABLE OUTCOMES WITH RT FOLLOWED BY ASCT IN LOW/LOW‐INTERMEDIATE SECONDARY AGE ADJUSTED IPI REL/REF DLBCL PATIENTS REFRACTORY TO SALVAGE CHEMOTHERAPY (2019) (2)
- Chapter 12 – Principles, Indications, and Techniques of Radiation Therapy of Lymphomas (2006) (2)
- NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Hodgkin Lymphoma, Version 2.2020 (2020) (2)
- Early Toxicities Associated with Radiation Based Conditioning for Relapsed/Refractory Hodgkin Lymphoma Patients Undergoing High Dose Therapy and Autologous Stem Cell Transplantation (HDT-ASCT) (2017) (2)
- Consolidation reduced dose whole brain radiotherapy (rdWBRT) following methotrexate, rituximab, procarbazine, vincristine, cytarabine (R-MPV-A) for newly diagnosed primary CNS lymphoma (PCNSL): Final results and long-term outcome. (2012) (2)
- A Century of Total Body Irradiation (TBI) (2009) (2)
- Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Amongst Radiation Oncology Residents (2019) (2)
- Effects of hormonal deprivation or stimulation on the radiosensitivity of human breast cancer cells (1991) (2)
- OUTCOMES OF 180 PATIENTS WITH INDOLENT LYMPHOMAS TREATED WITH VERY LOW DOSE (4 GY) RADIATION THERAPY ALONE (2019) (2)
- Chapter 75 – Hodgkin Lymphoma: Clinical Manifestations, Staging, and Therapy (2018) (2)
- Contrast media use in radiation oncology: a prospective, controlled educational intervention study with retrospective analysis of patient outcomes. (2010) (2)
- Excretion of Ascaris lumbricoides during total body irradiation. (1994) (2)
- Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma (2022) (1)
- Breast cancer in patients irradiated for hodgkin's disease: A clinical and pathological analysis of 44 events in 37 women (1991) (1)
- Medical Diary for the ensuing Week (1881) (1)
- Traditional and Modern Techniques for Radiation Treatment Planning (2011) (1)
- DOSE AND/OR VOLUME REDUCTION USING CONSOLIDATION VOLUME RADIATION THERAPY (CVRT) LOWERS DOSE TO HEART AND LUNGS IN EARLY‐STAGE HODGKIN LYMPHOMA PATIENTS WITH BULKY DISEASE (2017) (1)
- Autologous Hematopoietic Cell Transplant Outcomes after Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2021) (1)
- Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations (2016) (1)
- Excellent local control with involved-field radiotherapy following CHOP chemotherapy: analysis of 145 patients with early-stage intermediate-grade non-Hodgkin’s lymphoma (2001) (1)
- Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Salvage Chemotherapy (2019) (1)
- The Utility of Consolidative Upfront High Dose Chemoradiotherapy and ASCT in Patients with Mantle Cell Lymphoma (MCL). (2005) (1)
- TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE (2019) (1)
- Innovative Approaches to Radiation Treatment for Mycosis Fungoides in the Setting of Collagen Vascular Disease (2015) (1)
- A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma (2019) (1)
- 2584 : Health-Related Quality of Life in Long-Term Survivors of Autologous Hematopoietic-Cell Transplantation for Refractory and Relapsed Hodgkin’s Lymphoma (2006) (1)
- Low grade, indolent lymphomas of the head and neck: Comparative toxicity of standard versus very low dose radiation therapy (2018) (1)
- 18FDG-PET With CT Scan Co-Registration for Radiation Treatment Planning of Lymphoma Patients (2007) (1)
- Updates to the NCCN Guidelines (2013) (1)
- Combination immunochemotherapy followed by reduced dose (rd) whole brain radiation therapy (WBRT) in an expanded cohort of patients with newly diagnosed primary central nervous system lymphoma (PCNSL). (2016) (1)
- In Reply to Scarpelli et al. (2020) (1)
- In Reply to Zhang. (2017) (1)
- Characteristics and Outcomes of Patients With Lymphocyte-Predominant Hodgkin Lymphoma Versus Classical Hodgkin Lymphoma: A Population-Based Analysis (2014) (1)
- Synchronous and metachronous bilateral breast cancer: Are the risks greater in women with a history of radiation for Hodgkin lymphoma? (2009) (1)
- A Non-Stanford Mature Experience With Stanford V ± RT Regimen for Locally Extensive and Advanced Hodgkin's Lymphoma (HL) (2007) (1)
- Brentuximab Vedotin and AVD Chemotherapy Followed by ISRT: A Safe Primary Treatment Regimen for Early-Stage, Unfavorable Hodgkin Lymphoma (2016) (1)
- Clinical Impact of Bridging Therapy Prior to Commercial Chimeric Antigen Receptor (CAR) T-Cell Therapies for Relapsed/Refractory Lymphomas (2020) (1)
- Radiotherapy for Non-Hodgkin Lymphomas (2020) (1)
- Excellent long-term experience with primary bone lymphoma: Analysis of prognostic factors. (2004) (1)
- Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)". (2014) (1)
- Prognostic model for primary CNS lymphoma (PCNSL): Recursive partitioning analysis (RPA) of the MSKCC PCNSL population. (2006) (1)
- ILROG Lymphoma Mini-Atlas Part II, Hodgkin Lymphoma. (2020) (1)
- Involved-Site Radiation Therapy for H. Pylori-Independent Gastric MALT Lymphoma: 26 Years of Experience with 178 Patients (2018) (0)
- Local Therapy in the Definitive Management of Castleman Disease (2018) (0)
- Total lymphoid irradiation and high-dose chemotherapy followed by autologous bone marrow transplantation for relapsed or refractory Hodgkin's disease: 7-year experience (1992) (0)
- Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study (2022) (0)
- Influence of Post-second-line Chemotherapy PET Imaging and Involved Field Radiotherapy Prior to High Dose Therapy on Outcomes of Relapsed or Refractory Diffuse Large B Cell Lymphoma (2008) (0)
- Multiple myeloma (2001) (0)
- Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL). (2004) (0)
- MEASUREMENT OF VERY LOW CORROSION RATES IN CLOSED SYSTEMS. (1972) (0)
- A picture is worth a thousand words: a history of diagnostic imaging for lymphoma. (2021) (0)
- Combined modality therapy for advanced stage hodgkin's disease: patterns of relapse, prognostic factors and the role of radiation therapy (1990) (0)
- Identification of Gene Expression Signatures to Predict the Response of Low-Grade Lymphomas to Very Low Dose Radiation Therapy (2014) (0)
- Practice Patterns in Early Stage Hodgkin Lymphoma: Analysis of the National Cancer Database (2019) (0)
- NIMG-98. IDENTIFYING PATTERNS OF FAILURE AFTER INITIAL THERAPY IN PRIMARY CNS LYMPHOMA IN A LARGE PATIENT COHORT (2022) (0)
- Breast Cancer After Hodgkin Disease (2017) (0)
- What is the role of whole brain radiation therapy (WBRT) and high-dose cytarabine (Ara-C) as consolidation treatment after initial chemotherapy for primary CNS lymphoma (PCNSL)? (2007) (0)
- Treatment Modality Choices and Outcome in Langerhans Cell Histiocytosis: Radiation Therapy Versus Other Modalities (2018) (0)
- The outcome of patients with non-chemosensitive relapsed and refractory DLBCL salvaged with radiation therapy followed by autologous stem cell transplant. (2018) (0)
- Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice. (2020) (0)
- Lesion Characteristics and Patterns of Failure in Diffuse Large B Cell Lymphoma Patients Treated with Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy (2021) (0)
- Metabolic Tumor Volume and Total Lesion Glycolysis Can Predict Response to Very Low Dose Radiotherapy (4 Gy) in Indolent B-Cell Lymphomas (2021) (0)
- High Dose Chemoradiotherapy and ASCT Can Overcome the Prognostic Importance of Bcl-2, Bim, and p53 in Relapsed/Refractory Hodgkin’s Lymphoma. (2005) (0)
- Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies at Memorial Sloan Kettering Cancer Center (2021) (0)
- Immunohistochemi-NCCN Diffuse Large B-Cell Lymphoma Version 1 . 2016 Clinical Practice Guidelines in Oncology (2016) (0)
- Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma (2022) (0)
- [Acute myeloid leukemia: a late complication of the treatment for Hodgkin's disease]. (1983) (0)
- Primary cns lymphoma — Improved survival with an intensive combined modality treatment approach (1989) (0)
- Bronchial-Associated Lymphoid Tissue (BALT) Lymphoma: Characteristics and Treatment Outcome of 19 Cases. (2004) (0)
- Book Review Lymphoma of the Nervous System Edited by Tracy T. Batchelor. 207 pp., illustrated. Boston, Butterworth–Heinemann, 2004. $74.95. 0-7506-7406-7 (2004) (0)
- GRADE 3A FOLLICULAR LYMPHOMA CAN BE EFFECTIVELY CONTROLLED WITH VERY LOW DOSE RADIATION THERAPY (2019) (0)
- 2219 Primary bone lymphoma — characteristics, prognostic factors and the effect of treatment modality (1999) (0)
- Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015). (2022) (0)
- lymphoma cell transplantation for relapsed or primary refractory diffuse large B-cell Rituximab and ICE (RICE) as second-line therapy prior to autologous stem (2013) (0)
- changes in management, volume definition, and normal tissue dosimetry for many patients. A prospective trial is now underway to further characterize the impact of PET/CT in treatment planning for lymphoma patients. (2007) (0)
- Early breast cancer: significance and effectiveness of local control by conservative surgery and primary radiation therapy. (1988) (0)
- "Big Boom" Radiation Treatment (RT) of 4 Gy Single Fraction: Is It an Acceptable Alternative to "Boom Boom" Radiation Treatment 2 Gyx2 Fractions for Non-Hodgkin Lymphomas (NHL)? (2021) (0)
- 2156 Pulmonary complications following high dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) for non-Hodgkin's lymphoma (NHL): Analysis of risk factors (1996) (0)
- Investigation Characteristics and Outcomes of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Versus Those With Classical Hodgkin Lymphoma : A Population-Based Analysis (2015) (0)
- Initial Treatment Response Is Prognostic and Predictive of Relapse Patterns: Outcomes of >500 Patients Treated for Primary CNS Lymphoma (2022) (0)
- A Pilot Study Evaluating Lenalidomide and CC-486 in Combination with Radiotherapy for Patients with Plasmacytoma (LENAZART study) (2020) (0)
- [Primary adenocarcinoma of the appendix]. (1975) (0)
- High Local Control And Overall Survival With Radiotherapy For Anaplastic Large Cell Lymphoma (2020) (0)
- Cancer Management Chapter 26: Hodgkin lymphoma (2010) (0)
- The NCCN Non-Hodgkin ’ s Lymphomas Clinical Practice Guidelines in OncologyTM (2010) (0)
- toxicities and long term survival after autologous hematopoietic stem cell transplantation for older patients with relapsed refractory hodgkin lymphoma (2019) (0)
- SAFETY AND EARLY DATA FROM A PHASE II TRIAL OF PEMBROLIZUMAB (PEM) AND ENTINOSTAT (ENT) IN RELAPSED AND REFRACTORY (R/R) HODGKIN LYMPHOMA (HL) AND FOLLICULAR LYMPHOMA (FL) (2019) (0)
- Proceeding of the 37th Annual ASTRO meeting ASTRO refresher course abstract403 Hodgkin's disease — part 2: Management of advanced disease, relapsed disease, and long-term complications of treatment (1995) (0)
- Adjubant chop chemotherapy following radiotherapy in stage I low and intermediate grade non-hodgkin's lymphoma: Results of a prospective randomized study (1991) (0)
- 2222 Improving the accuracy of tumor volume localization by the use of CT-simulation in patients with Hodgkin's disease (1999) (0)
- Long-term Outcome of High-dose Salvage Chemoradiation for Patients with Early Stage Hodgkin Lymphoma (HL) Who Failed Initial Treatment with Combined Modality Treatment (CMT) or Chemotherapy Alone (C) (2010) (0)
- Should a Bulky Mediastinal Mass ≥7cm in the Longest Dimension be Considered an Adverse Prognostic Factor in Patients with Advanced Hodgkin Lymphoma and Negative Interim PET/CT? (2019) (0)
- Response Rates of Nodal Versus Extranodal Follicular and Marginal Zone Lymphomas to Very Low Dose Radiation Therapy of Only 4 Gy (2018) (0)
- Langerhans Cell Histiocytosis (LCH) in the Modern Era: Excellent Local Control With Radiation Therapy (RT). (2016) (0)
- Primary Follicular Lymphoma of the Gastrointestinal Tract: Importance of Stage and Treatment Regimen (2011) (0)
- CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA (2021) (0)
- Radiation Therapy for Patients with Diffuse Large B Cell Richter's Syndrome of CLL (2021) (0)
- Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes (2022) (0)
- Lymphoma: advances in imaging and radiotherapy - introductory editorial. (2021) (0)
- Safety and Efficacy of Splenic Irradiation for Non-Hodgkin Lymphoma (2022) (0)
- 166 oral GASTRIC MALT LYMPHOMA: LONG-TERM EXCELLENT OUTCOME OF 103 PATIENTS TREATED WITH RADIOTHERAPY ALONE (2011) (0)
- Basic Fibroblast Growth Factor Confers Growth Inhibition and Mitogen-activated Protein Kinase Activation in Human Breast Cancer Cells 1 (2005) (0)
- SP-0208: Radiotherapy of Hodgkin Lymphoma: Revolutionary Roots, Challenging Present, Bright Horizons (2018) (0)
- FDG-PET scanning for detection, staging and treatment planning of extranodal marginal zone lymphomas (2004) (0)
- Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma: Improving Outcome by Incorporating Involved Field Radiotherapy into a Comprehensive Second-Line High-Dose Therapy Strategy. (2007) (0)
- Overexpression of basic fibroblast growth factor confers negative growth regulation and radiosensitization in human breast cancer cells (1994) (0)
- Principles of Radiation Therapy for Hodgkin Lymphoma (2020) (0)
- Assessment of Lymphoma and Other Hematologic Malignancies Training Needs Among Radiation Oncology Residents: a Brief Report (2021) (0)
- Accelerated Total Lymphoid Irradiation (TLI) as an Integral Component of High-dose Therapy (HDT) Salvage Regimen for Patients with Refractory and Relapsed Hodgkin Lymphoma (HL): 20 Years of Experience with 186 Patients (2009) (0)
- A Proof-of-Principle Study of Split-Course Bridging Radiotherapy Prior to Commercial CD19 CAR T-Cell Therapies for Patients With Relapsed or Refractory B-Cell Lymphomas. (2021) (0)
- Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma (2022) (0)
- 2038 Autologous bone marrow transplantation following high-dose chemotherapy with or without accelerated hyperfractionated total lymphoid irradiation for patients with refractory or relapsed Hodgkin's disease (1995) (0)
- Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma. (2007) (0)
- Positron Emission Tomography/Computed Tomography in Radiotherapy Treatment Planning (2010) (0)
- Feasibility and preliminary efficacy of R-CHOP-14 in patients with diffuse large B-Cell lymphoma (DLBCL) (2004) (0)
- No need for routine radiologic surveillance in early stage Hodgkin lymphoma (HL) treated with combined ABVD and radiotherapy (2014) (0)
- Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Therapy (2019) (0)
- Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019 (2022) (0)
- CLINICAL CHARACTERISTICS AND OUTCOMES OF STAGE I DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB‐ERA (2019) (0)
- Primary Central Nervous System Lymphoma (2018) (0)
- Predictors of Response to Very Low Dose Radiotherapy (4Gy) for Indolent B-Cell Lymphomas: Is 4Gy Also Suitable for Potentially Curable Patients? (2021) (0)
- Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience (2021) (0)
- How I treat How I treat extramedullary acute myeloid leukemia (2011) (0)
- Five-Year Experience Using Bridging Radiotherapy Prior to Chimeric Antigen Receptor (CAR) T-Cell Therapies for B-Cell Malignancies (2022) (0)
- Local Recurrence After Radiation Therapy for Langerhans Cell Histiocytosis: Risk Stratification by Site of Disease (2017) (0)
- Long-term outcomes of survivors of autologous hematopoietic-cell transplantation for refractory and relapsed Hodgkin's Disease. (2006) (0)
- Favorable Outcomes of Patients with Limited-Stage Ocular Adnexal DLBCL Treated in the Rituximab Era: Long-Term Follow-up of a Single Center Experience (2021) (0)
- Primary Intraocular Lymphoma: Excellent Outcomes With Ocular Radiation Therapy Alone (2012) (0)
- Identification of effective therapy in Langerhans cell histiocytosis in the adult population. (2017) (0)
- Treatment of Primary Central Nervous System Lymphoma with Cranial Irradiation and Combined Modality Therapy (2012) (0)
- T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory Hodgkin lymphoma (2022) (0)
- Relapsed and Primary Refractory Diffuse Large Cell Lymphoma (DLCL) Salvaged With Involved Field Radiotherapy (IFRT) & High Dose Chemotherapy (HDCT) Followed by Autologous Stem Cell Transplantation (ASCT) (2007) (0)
- "Big Boom" (4 Gy x 1) Radiation Treatment (RT) Versus "Big Boom" (2 Gy x 2) for Non-Hodgkin Lymphoma (NHL) (2022) (0)
- Efficacy and Toxicity of Alternative Radiation Treatment Schemes for Patients With Hematologic Malignancies: A Collaborative ILROG COVID Era Report (2021) (0)
- Future Prospects for Radiotherapy for Hodgkin Lymphoma (2011) (0)
- Early-Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma: The Impact of Radiation Therapy on Overall Survival (2015) (0)
- Non-Hodgkin's LymphomasPractice Guidelines in Oncology TM (2010) (0)
- INCIDENCE AND TREATMENT OUTCOMES OF PATIENTS WITH TRANSFORMED MARGINAL ZONE LYMPHOMA TREATED WITH RCHOP‐LIKE REGIMENS (2019) (0)
- 303C Hodgkin's disease part 1: Pathology, staging, and management of early stage disease (1995) (0)
- Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting (2023) (0)
- Overall survival in patients with Hodgkin lymphoma: Disparities by insurance status. (2015) (0)
- Non-Hodgkin’s Lymphomas (1999) (0)
- Prediction of Response to Very Low Dose Radiotherapy (4 Gy) in Mature B-Cell Lymphomas Using Metabolic Tumor Volume. (2021) (0)
- Radiotherapy is an Effective Definitive Treatment for Limited Stage Grade 3A Follicular Lymphoma (2019) (0)
- Modern radiation therapy for hodgkin lymphom-target definition and dose guidelines from the international lymphoma radiation oncology group (2017) (0)
- Predictors of initial treatment in older adults with follicular non-Hodgkin lymphoma (2007) (0)
- SP-0022 State of the art for indolent lymphoma (2019) (0)
- Brentuximab Vedotin Combined with Chemotherapy in Newly Diagnosed, Early-Stage, Unfavorable-Risk Hodgkin Lymphoma: Extended Follow-up with Evaluation of Baseline Metabolic Tumor Volume and PET2 (2022) (0)
- Primary Hepatic Lymphoma: Role of Low-Dose Radiotherapy at a Single Institution with Genetic Characterization and Paired Literature Review (2022) (0)
- 2527 : Quality of Radiotherapy Reporting in Randomized Controlled Trials (RCTs) of Hodgkin Disease (HD) and Non-Hodgkin Lymphoma (NHL) (2006) (0)
- Radioactive tracers for inhibitor evaluation (1971) (0)
- Highly favorable outcomes with salvage radiation therapy and autologous hematopoietic cell transplantation in relapsed and refractory DLBCL patients with minimal to no response to salvage chemotherapy (2022) (0)
- Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era (2022) (0)
- 9203 Accelerated total lymphoid irradiation (TLI)-containing salvage regimen for patients with refractory and relapsed Hodgkin lymphoma (HL): 20 years outcome with multivariate analysis (2009) (0)
- Salivary Gland Tumors as Secondary Neoplasms: A Report of 18 Cases and a Review of the Literature (2003) (0)
- 61 – Non-Hodgkin's Lymphomas (2010) (0)
- Deauville Dubiosity. (2020) (0)
- Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma (2022) (0)
- LANGERHANS CELL HISTIOCYTOSIS IN ADULTS IS ASSOCIATED WITH INCREASED HEMATOLOGIC AND SOLID MALIGNANCIES (2017) (0)
- Contrast Media Use in Radiation Oncology: An Educational Intervention Study with Retrospective Analysis of Patient Outcomes (2010) (0)
- Curative radiation for orbital MZL: how much? (2017) (0)
- Bridging Radiation Rapidly and Effectively Cytoreduces High Risk Relapsed/Refractory Aggressive B-Cell Lymphomas Prior to Chimeric Antigen Receptor T-Cell Therapy. (2022) (0)
- Vacuolar-proton-ATPase is involved in the response of cancer cells to ionizing radiation and is a new target for radiosensitization (2001) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joachim Yahalom?
Joachim Yahalom is affiliated with the following schools:
